You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 11,414,489


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,414,489
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 11,414,489

Introduction

When analyzing a patent, particularly one like United States Patent 11,414,489, it is crucial to delve into the specifics of the claims, the inventors, and the broader patent landscape. This analysis will help in understanding the patent's validity, its position within the industry, and potential challenges it might face.

Understanding Patent Claims

Definition and Importance

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. For a patent like 11,414,489, the claims must be carefully crafted to ensure they are clear, definite, and cover the entire scope of the invention[1].

Conception and Reduction to Practice

In the U.S., determining inventorship focuses on the conception of the idea, which is the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. This conception must include every feature of the subject matter claimed in the patent. The reduction to practice, while important, does not alone qualify someone as an inventor unless they contributed to the conception[1].

Inventorship Determination

Who Are the True and Only Inventors?

For a patent like 11,414,489, identifying the true and only inventors is critical. An inventor is someone who conceives the subject matter of at least one claim of the patent. This can include individuals who collaborate to produce the invention through aggregate efforts. However, those who only reduce the invention to practice by exercising ordinary skill in the art are not considered inventors[1].

Consequences of Incorrect Inventorship

Incorrect or deceptive inventorship can lead to the patent being invalid and unenforceable. Even if the correct inventorship can be established later, a patent obtained through fraud remains unenforceable. This underscores the importance of accurate inventorship determination from the outset[1].

The Patent Trial and Appeal Board (PTAB)

Role in Patent Validity Challenges

The PTAB, established by the Leahy-Smith America Invents Act (AIA), plays a significant role in challenging the validity of patents. Inter partes review (IPR) and post-grant review (PGR) are administrative procedures that allow parties to challenge patent validity before the PTAB, which is often faster and less expensive than federal court litigation. This can be particularly relevant for patents like 11,414,489, as it provides an alternative avenue for challenging patent validity[2].

Advantages Over Federal Court Litigation

PTAB procedures use a lower standard of proof (preponderance of the evidence) compared to federal court litigation (clear and convincing evidence). This makes it more feasible for entities to challenge patents without the high costs and lengthy timelines associated with federal court cases[2].

Subject Matter Eligibility

The Alice/Mayo Test

For patents, especially those involving AI or software, subject matter eligibility is a critical issue. The Alice/Mayo test is used to determine if patent claims are directed to ineligible subject matter such as laws of nature, natural phenomena, or abstract ideas. If the claims are directed to such subject matter, they must have an "inventive concept" that transforms the nature of the claim into something significantly more than the ineligible concept itself[2].

Practical Applicability Analysis

The 2024 Guidance Update from the USPTO emphasizes the importance of practical applicability analysis under Step 2A, Prong Two, for AI inventions. This involves demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem. This is crucial for overcoming section 101 rejections and ensuring the patentability of AI-related inventions[5].

Patent Assertion Entities (PAEs)

Impact on Patent Landscape

PAEs, often referred to as "patent trolls," can significantly impact the patent landscape. They typically acquire and assert patents, often targeting a wide range of industries. The FTC study on PAEs highlights two business models: Portfolio PAEs and Litigation PAEs. Portfolio PAEs negotiate licenses for large portfolios without necessarily suing, while Litigation PAEs often precede licensing with patent infringement suits. Understanding the activities of PAEs can provide insights into potential licensing and litigation strategies related to a patent like 11,414,489[3].

Conducting a Preliminary Patent Search

Tools and Databases

To analyze the patent landscape around 11,414,489, conducting a thorough patent search is essential. The USPTO provides several tools, including the Patent Public Search database and the Cooperative Patent Classification (CPC) database. These tools allow for full-text searching of patent grants and applications from the U.S. and over 100 other patent offices worldwide[4].

Key Considerations for Patent 11,414,489

Claim Scope and Inventorship

  • Ensure that the claims are clear and cover the entire scope of the invention.
  • Verify that the listed inventors are the true and only inventors who conceived the subject matter of the claims.

Subject Matter Eligibility

  • Analyze the claims under the Alice/Mayo test to ensure they are not directed to ineligible subject matter.
  • Demonstrate practical applicability under Step 2A, Prong Two, if the patent involves AI or software-related inventions.

PTAB and Litigation Strategies

  • Be aware of the potential for IPR or PGR challenges and the advantages of these procedures over federal court litigation.
  • Consider the strategies employed by PAEs and how they might impact the patent.

Patent Search and Analysis

  • Use comprehensive patent search tools to identify prior art and similar patents.
  • Analyze the patent landscape to understand the competitive environment and potential challenges.

Potential Challenges and Mitigation Strategies

Challenges from PTAB Proceedings

  • Be prepared for potential IPR or PGR challenges by ensuring the patent claims are robust and well-supported by prior art and technical documentation.

Litigation from PAEs

  • Understand the business models of PAEs and be prepared for licensing negotiations or litigation.
  • Ensure that the patent is well-documented and that inventorship is accurately determined to avoid challenges.

Subject Matter Eligibility Rejections

  • Craft strong arguments under Step 2A, Prong Two, to overcome section 101 rejections.
  • Demonstrate the practical applicability and technological advancements of the invention.

Key Takeaways

  • Accurate inventorship determination is crucial for the validity and enforceability of a patent.
  • The PTAB provides an efficient and cost-effective avenue for challenging patent validity.
  • Subject matter eligibility analysis, particularly for AI and software patents, is critical for overcoming section 101 rejections.
  • Conducting thorough patent searches and analyzing the patent landscape are essential for understanding the competitive environment and potential challenges.
  • Being aware of PAE activities and strategies can help in preparing for licensing and litigation scenarios.

FAQs

What is the importance of accurate inventorship in a patent application?

Accurate inventorship is crucial because incorrect or deceptive inventorship can lead to the patent being invalid and unenforceable.

How does the PTAB differ from federal court litigation in challenging patent validity?

The PTAB uses a lower standard of proof (preponderance of the evidence) and is generally faster and less expensive than federal court litigation.

What is the Alice/Mayo test, and how does it apply to AI inventions?

The Alice/Mayo test determines if patent claims are directed to ineligible subject matter. For AI inventions, demonstrating practical applicability under Step 2A, Prong Two, is key to overcoming section 101 rejections.

What are the two main business models of Patent Assertion Entities (PAEs)?

PAEs operate under two main models: Portfolio PAEs, which negotiate licenses for large portfolios, and Litigation PAEs, which often precede licensing with patent infringement suits.

How can a thorough patent search help in analyzing the patent landscape?

A thorough patent search using tools like the Patent Public Search database and CPC database helps identify prior art, similar patents, and the competitive environment, providing valuable insights into potential challenges and opportunities.

Sources

  1. Determining Inventorship for US Patent Applications. Oregon State University.
  2. The Patent Trial and Appeal Board and Inter Partes Review. Congressional Research Service.
  3. Patent Assertion Entity Activity: An FTC Study. Federal Trade Commission.
  4. Advanced Patent Searching. Clemson University Libraries.
  5. The Importance of Prong Two of Step 2A for AI Inventions. Baker Botts.

More… ↓

⤷  Subscribe

Details for Patent 11,414,489

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 May 05, 2004 ⤷  Subscribe
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 December 02, 2004 ⤷  Subscribe
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 October 26, 2004 ⤷  Subscribe
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.